Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

County-Level Data Reveal Three-Fold Difference in Diabetes Prevalence Across the U.S.

Immune Therapeutics
Posted on: 25 Aug 16

ALEXANDRIA, Va., Aug. 23, 2016 /PRNewswire-USNewswire/ -- A county-level analysis of diabetes data in the United States reveals wide variations in prevalence across the country, with a three-fold difference in prevalence among counties with the highest and lowest rates. The analysis also finds stark differences among rates of diagnosis, diabetes awareness and effective treatment, which could help policymakers and healthcare providers identify areas in need of greater public health resources. The analysis was published in Diabetes Care on August 23, 2016.

The analysis showed that total diabetes prevalence (including diagnosed and undiagnosed) ranged from 8.8 percent (Los Alamos County, NM) to 26.4 percent (Starr County, TX) of the population among American counties in 2012. Overall, counties in the deep South (excluding Florida), those close to the Mexican border in Texas, and counties with Native American reservations in the Four Corners region of the Southwest and in North and South Dakota, exhibited the highest prevalence. Prevalence was lowest in counties in the upper West and Midwest, parts of Alaska and parts of New England. Colorado, interestingly, was home to seven of the top 10 counties with the lowest prevalence.

For more information:

Editor's Details

Mike Wood

Last updated on: 25/08/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.